Invisible Disease

Hep Talk by Larry Buhl Organizations shine a light on HCV in jails and prisons The percentage of people chronically infected with hepatitis C (HCV) in...

Final Results of the PARTNER2 Study Confirm: U=U

Final Results of the PARTNER2 Study Confirm: U=U Eight years, 1,000 serodiscordant gay male couples, and zero HIV transmissions by Hank Trout The final results of the...

Process of Elimination

As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s...

Clearing Hurdles

What can we do to address the obstacles to HCV treatment? by Larry Buhl Hepatitis C (HCV) is a “silent killer” in more ways than one....

Man to Man

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the...

Gateway to Justice

It’s a state with a relatively low prevalence of HIV, but a high number of convictions for HIV non-disclosure and some of the nation’s...

amfAR’s Opioid and Health Indicators Database

Big Data New amfAR database shows the extent of the opioid emergency by Larry Buhl In the wake of the dramatic 2015 outbreak of HIV and hepatitis...

African Americans & HCV

"Race" Matters Researchers study disparities when it comes to African Americans & HCV by Larry Buhl               A growing number of clinicians and researchers want the African-American community...

The Lovely “The #HIVDayShitList”: Josh Robbins

The Lovely “The #HIVVDayShitList” by Josh Robbins LOVE. It’s a word I’ve been tossing around my entire life. I’ve said it to my parents, mostly to my...

One-Stop Hep C Care at Alameda Health

While potent new direct-acting antiviral (DAA) therapy has revolutionized treatment hepatitis C by shortening treatment and offering an actual cure, there has been one...

LATEST POSTS

Hep Community: We Need More Federal Dollars

Money Talks The hepatitis community wants more federal dollars; hep a cases rising fast by Larry Buhl Here’s the good news on federal funding for hepatitis research...

Joe Ede: Advocate